IDEAYA Biosciences (IDYA) Tops Q3 EPS by 133c

IDEAYA Biosciences (NASDAQ: IDYA) reported Q3 EPS of $1.33. Revenue for the quarter came in at $207.83 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.

You May Also Be Interested In

• Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?
• BNP Paribas Exane Upgrades Subsea 7 SA (SUBC:NO) (SUBCY) to Outperform
• U.S. officials have told CBS News that there are no "new" or novel negotiations planned